Statistics for Disease duration and hla-b27 positivity alter longterm retention rate of certolizumab pegol in patients with psoriatic arthritis
Total visits
| views | |
|---|---|
| Disease duration and hla-b27 positivity alter longterm retention rate of certolizumab pegol in patients with psoriatic arthritis | 1 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 1 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| Pehlivan_vd_2021.pdf | 14 |